Presentation (CTI)

OBJECTIVES: The PanCareSurPass project aims to improve survivorship care for children and adolescents diagnosed with cancer across Europe. Despite an 80% survival rate, significant disparities in follow-up care persist. To address this, the project introduces the SurPass v2.0 digital survivorship passport in clinics across Austria, Belgium, Germany, Italy, Lithuania, and Spain. This abstract outlines the development of a health economic evaluation framework to assess the implementation of SurPass v2.0, supported by the EU Horizon 2020 program.The framework serves two main purposes: (1) to compare the outcomes and costs of SurPass v2.0 implementation, and (2) to support evidence-based decision-making at local, regional, and national levels.
METHODS: The framework consists of three components:

1. Cost Utility Analysis (CUA): Evaluates cost per quality-adjusted life year (QALY) gained using the EQ-5D-5L(-Y) instrument. Cost categories are informed by literature and expert input and include survivor-, provider-, payer-, and system-level costs, further divided into implementation, operational, and patient costs.
2. Multi-Criteria Decision Analysis (MCDA): Incorporates broader outcomes such as patient activation, education, empowerment, and perceived usefulness. Stakeholder-informed online workshops guide the weighting of criteria.
3. Prediction Model: Integrates CUA and MCDA results, accounting for country-specific healthcare contexts and digital readiness.

RESULTS: Three cost reporting tools were developed: a hospital-level tool, a healthcare provider survey, and a caregiver/survivor questionnaire. These tools capture detailed cost data and stakeholder perspectives. MCDA produces an overall value score that feeds into the prediction model.
CONCLUSIONS: This framework offers a comprehensive, adaptable approach to evaluating digital implementations such as the survivorship care tool PanCare SurPass v2.0.